Peter R. Carroll, MD, MPH

University of California, Berkeley, BA, 1974, Zoology
Georgetown University School of Medicine, Washington, D.C., MD, 1979, Medicine
University of California, Berkeley, MPH, 2008

• 1984-1986
  Fellow, Urology Service, Memorial Sloan-Kettering Cancer Center
• 1986-1992
  Assistant Professor in Residence, Dept. of Urology, University of California, S.F
• 1992-1993
  Associate Professor, Dept. of Urology, University of California, San Francisco
• 1996-present
  Program Leader, Program in Urologic Oncology, UCSF Cancer Center
• 1996-present
  Professor and Chair, Department of Urology, UCSF, San Francisco, CA
• 2003-present
  Surgeon-in-Chief, UCSF Helen Diller Family Comprehensive Cancer Center
• 2006-present
  Director of Clinical Services and Strategic Planning, UCSF Helen Diller Family Comprehensive Cancer Center
• 2006-present
  Associate Dean, UCSF School of Medicine

• Other Experience and Professional Memberships
• 2002-present
  American Urological Association, Prize Essay Committee (Chair)
• 2002-2008
  American Urological Association, Update Series Advisory Committee (member)
• 2001-present
  American Board of Urology, Trustee, President Elect (2006-2008)
• 2001-present
  American College of Surgeons Commission on Cancer, AUA representative
• 2000-present
  American Association of Genitourinary Surgeons, Site Committee
• 2003-present
  American Association of Genitourinary Surgeons, Councilor
• 2004-present
  ASCO Prostate Cancer Committee, Symposium Committee
• 2004-present
  ASCO, Oncology Taskforce
• 2005-present
  ASCO, Cancer Communications Committee, Roster of Cancer Experts
• 2005-present
  American College of Radiology’s Appropriateness Criteria Expert Panel on Radiation Oncology-Prostate, AUA representative
• 2006-present
  The Journal of Urology, Associate Editor
• 2011 – present
  AUA Update, Editor
• Honors:
• 2001
  Ken and Donna Derr - Chevron Endowed Chair in Prostate Cancer
• 2002
  Clinical Society of the American Association of Genitourinary Surgeons
• 2004
  Ken and Donna Derr-Chevron Distinguished Professorship in Prostate Cancer
• 2010
  AUA Eugene Fuller Triennial Prostate Award
• 2010
  Society of Urologic Oncology Medal

• (selected from over 400)
• Arredondo SA, Elkin EP, Marr PL, Latini DM, DuChane J, Litwin MS, Carroll PR; CaPSURE Investigators. Impact of comorbidity on health-related quality of life in men undergoing radical prostatectomy: data from CaPSURE. Urology. 2006 Mar;67(3):559-65.
• Latini DM, Chan JM, Cowan JE, Arredondo SA, Kane CJ, Penson DF, DuChane J, Carroll PR. Health-related quality of life for men with prostate cancer and diabetes: a longitudinal analysis from CaPSURE. Urology 2006;68(6):1242-7.
• Bellizzi KM, Latini DM, Cowan JE, DuChane J, Carroll PR. Fear of recurrence, symptom burden, and health-related quality of life in men with prostate cancer. Urology. 2008 Dec;72(6):1269-73.
• Arredondo SA, Downs TM, Lubeck DP, Pasta DJ, Silva SJ, Wallace KL, Carroll PR. Watchful waiting and health related quality of life for patients with localized prostate cancer: data from CaPSURE. J Urol. 2008 May;179(5 Suppl):S14-8.
• Wu AK, Cooperberg MR, Sadetsky N, Carroll PR. Health related quality of life in patients treated with multimodal therapy for prostate cancer. J Urol. 2008 Dec;180(6):2415-22.
• Davies BJ, Smaldone MC, Sadetsky N, Dall'era M, Carroll PR. The impact of obesity on overall and cancer specific survival in men with prostate cancer. J Urol 2009;182(1):112-7.
• Cooperberg MR, Broering JM, Carroll PR. Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis. J Natl Cancer Inst. 2009 Jun 16;101(12):878-87. Epub 2009 Jun 9. PubMed Central PMCID: PMC2697208.
• Cooperberg MR, Vickers AJ, Broering JM, Carroll PR. Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer. Cancer. 2010 Nov 15;116(22):5226-34. doi: 10.1002/cncr.25456. PubMed Central PMCID: PMC2975879.
• Reese AC, Sadetsky N, Carroll PR, Cooperberg MR. Inaccuracies in assignment of clinical stage for localized prostate cancer. Cancer. 2010 Nov 22. [Epub ahead of print] PubMed PMID: 21104818.
• Le JD, Cooperberg MR, Sadetsky N, Hittelman AB, Meng MV, Cowan JE, Latini DM, Carroll PR; CaPSURE Investigators. Changes in specific domains of sexual function and sexual bother after radical prostatectomy. BJU Int. 2010 Oct;106(7):1022-9.
• Cooperberg MR, Cowan JE, Hilton JF, Reese AC, Zaid HB, Porten SP, Shinohara K, Meng MV, Greene KL, Carroll PR. Outcomes of active surveillance for men with intermediate-risk prostate cancer. J Clin Oncol. 2011 Jan 10;29(2):228-34. Epub 2010 Nov 29. ; PubMed Central PMCID: PMC3058278.
• Whitson JM, Porten SP, Carroll PR. Prostate cancer: reducing overtreatment: active surveillance in low-risk disease. Nat Rev Urol. 2011 Mar;8(3):124-5. Epub 2011 Feb 8. PubMed PMID: 21304508.
• Porten SP, Whitson JM, Cowan JE, Cooperberg MR, Shinohara K, Perez N, Greene KL, Meng MV, Carroll PR. Changes in Prostate Cancer Grade on Serial Biopsy in Men Undergoing Active Surveillance. J Clin Oncol. 2011 May 31. [Epub ahead of print] PubMed PMID: 21632511.
• Richman EL, Kenfield SA, Stampfer MJ, Paciorek A, Carroll PR, Chan JM. Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavor. Cancer Res. 2011 Jun 1;71(11):3889-95.
• Cooperberg MR, Hilton JF, Carroll PR. The CAPRA-S score: A Straightforward Tool for Improved Prediction of Outcomes After Radical Prostatectomy. Cancer. 2011 Jun 3. doi: 10.1002/cncr.26169. [Epub ahead of print] PubMed PMID: 21647869.